← Back to Analyst Consensus 
CGTX Buy
COGNITION THERAPEUTICS INC
Current Price —
Implied Upside —
Analysts 9
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 18, 2026 (23 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Mar 27, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Dec 4, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $3 | 44% |
| Nov 21, 2025 | B. Riley Securities | reiterate | Buy → Buy | $3 | 55% |
| Nov 19, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $3 | 44% |
| Aug 8, 2025 | Chardan Capital | maintain | Buy → Buy | $4 | 47% |
| Jun 26, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $3 | 44% |
| May 27, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $3 | 44% |
| May 8, 2025 | Chardan Capital | maintain | Buy → Buy | $4 | 47% |
| Mar 24, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $5 | 44% |
| Mar 21, 2025 | Chardan Capital | maintain | Buy → Buy | $8 | 47% |
| Feb 26, 2025 | Chardan Capital | maintain | Buy → Buy | $11 | 47% |
| Dec 19, 2024 | B. Riley Securities | upgrade | Neutral → Buy | $1.5 | 55% |
| Dec 19, 2024 | Chardan Capital | maintain | Buy → Buy | $11 | 47% |
| Dec 19, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $6 | 44% |
| Nov 27, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Nov 15, 2024 | Chardan Capital | maintain | Buy → Buy | $11 | 47% |
| Nov 4, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Oct 31, 2024 | Chardan Capital | maintain | Buy → Buy | $11 | 47% |
| Aug 12, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $5 | 44% |
| Aug 6, 2024 | B. Riley Securities | downgrade | Buy → Neutral | $1 | 55% |
| Aug 1, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $7 | 44% |
| Jul 30, 2024 | Cantor Fitzgerald | downgrade | Overweight → Neutral | $0 | 50% |
| Jul 2, 2024 | Rodman & Renshaw | reiterate | Buy → Buy | $14 | 40% |
| Jun 6, 2024 | Chardan Capital | initiate | — → Buy | $11 | 47% |
| May 29, 2024 | HC Wainwright & Co. | initiate | — → Buy | $10 | 44% |
| Mar 28, 2024 | B. Riley Securities | reiterate | Buy → Buy | $5 | 55% |
| Mar 27, 2024 | Oppenheimer | maintain | Outperform → Outperform | $9 | 52% |
| Aug 14, 2023 | Ladenburg Thalmann | maintain | Buy → Buy | $6 | 45% |
| May 9, 2023 | Oppenheimer | reiterate | — → Outperform | $9 | 52% |
| Mar 24, 2023 | Oppenheimer | reiterate | — → Outperform | $9 | 52% |
| Sep 29, 2022 | Cantor Fitzgerald | initiate | — → Overweight | $12 | 50% |
| Apr 22, 2022 | Ladenburg Thalmann | initiate | — → Buy | $10 | 45% |
| Nov 3, 2021 | Oppenheimer | initiate | — → Outperform | $22 | 52% |
Price Target Trend
Mar 26, 2026 Oct 26, 2026
EPS Estimates
+1y —
+1q —
0q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days